See more news releases in: OTC, SmallCap, Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Surveys, Polls and Research
Cord Blood America Says Outreach Program to OB/GYN Nurses, Insurance Case Workers, Paying Significant Dividends
LAS VEGAS, Sept. 8 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life-saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today Dr. Geoffrey John O'Neill, its Medical Director, was interviewed by analyst Francis Gaskins. The interview concerned the Company's outreach program to nurses and case workers on the value of storing umbilical cord blood.
The entire interview is available at: http://gaskinsco.com/cbai-9-2-10.mp3
In the interview, Dr. O'Neill explains the importance of talking to case workers for insurance companies, and OB/GYN nurses about the value of cord blood storage. "These are the people who are in constant contact with the pregnant patient and her family. Doctors are often too busy to spend the time on this issue. No other company has an outreach program like we do and we are very proud of it and its successes."
Prior to joining Cord Blood America, Dr. O'Neill was Laboratory and Scientific/Medical Director for Cryo-Cell International Inc. in Florida and was Laboratory Director for the Bio-Matrix Scientific Group Inc., a San Diego biotech research and development firm in the stem cell sector. He received a Ph.D. in Immunology from the University of Glasgow, Scotland, and is the author or co-author of more than 75 publications in his field in which he has won a number of significant honors.
About Cord Blood America
Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.
SOURCE Cord Blood America, Inc.
Back to top
RELATED LINKS
http://www.cordblood-america.com
http://www.corcell.com
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
PR Newswire Membership
Fill out a PR Newswire membership form or contact us at (888) 776-0942.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
Featured Video
More in These Categories
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Free Investing Newsletter from Investor Uprising!
Learn to navigate the world's financial system and profit from leading companies.
Register for Investor Uprising, the people's investment site, for a free weekly newsletter, information, education and premium research including our latest IU Confidential Report - "All The Glitters: The Ultimate Gold Report".